According to Lee et al. (2013) [27], monocytes from newly discovered untreated T2DM patients have increased expression of the inflammasome’s NLRP3 and ASC, as well as enhanced Caspase-1 activation. Here, NLRP3 is linked to type 2 diabetes mellitus.